+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats

Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats

Circulation Research 83(9): 877-888

The plasma membrane calmodulin-dependent calcium ATPase (PMCA) is a calcium-extruding enzyme controlling Ca2+ homeostasis in nonexcitable cells. However, its function in the myocardium is unclear because of the presence of the Na+/Ca2+ exchanger. We approached the question of the physiological function of the calcium pump using a transgenic "gain of function" model. Transgenic rat lines carrying the human PMCA 4 cDNA under control of the ventricle-specific myosin light chain-2 promoter were established, and expression in the myocardium was ascertained at the mRNA, protein, and functional levels. In vivo hemodynamic measurements in adult homozygous animals showed no differences in baseline and increased cardiac performance recruited by volume overload compared with controls. No differences between transgenic and control cardiomyocytes were found in patch clamp voltage dependence, activation/inactivation behavior of the L-type Ca2+ current, or fast [Ca2+]i transients (assessed by the Fura-2 method). To test whether the PMCA might be involved in processes other than beat-to-beat regulation of contraction/relaxation, we compared growth processes of neonatal transgenic and control cardiomyocytes. A 1.6- and 2.3-fold higher synthesis rate of total protein was seen in cells from transgenic animals compared with controls on incubation with 2% FCS for 24 hours and 36 hours, respectively. An effect of similar magnitude was observed using 20 micromol/L phenylephrine. A 1.4-fold- and 2.0-fold-higher protein synthesis peak was seen in PMCA-overexpressing cardiomyocytes after stimulation with isoproterenol for 12 hours and 24 hours, respectively. Because pivotal parts of the alpha- and beta-adrenergic signal transduction pathways recently have been localized to caveolae, we tested the hypothesis that the PMCA might alter the amplitude of alpha- and beta-adrenergic growth signals by virtue of its localization in caveolae. Biochemical as well as immunocytochemical studies suggested that the PMCA in large part was colocalized with caveolin 3 in caveolae of cardiomyocytes. These results indicate that the sarcolemmal Ca2+-pump has little relevance for beat-to-beat regulation of contraction/relaxation in adult animals but likely plays a role in regulating myocardial growth, possibly through modulation of caveolar signal transduction.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 046897313

Download citation: RISBibTeXText

PMID: 9797336

DOI: 10.1161/01.res.83.9.877

Related references

Overexpression of the sarcolemmal calcium pump increases susceptibility to ischemia/reperfusion injury in transgenic rat hearts. Circulation 100(18 SUPPL ): I 7, Nov 2, 1999

Regulation of nitric oxide synthase I in the myocardium by the sarcolemmal calcium pump. Circulation 102(18 Supplement): II 117, October 31, 2000

Potential role of the sarcolemmal calcium-pump in normal and hypertrophied myocardium. European Heart Journal 14(ABSTR SUPPL ): 331, 1993

Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 281(3): R699-R705, 2001

L-NAME alters growth response in normal, but not in transgenic cardiomyocytes overexpressing the sarcolemmal calcium pump. Circulation 98(17 SUPPL ): I680, Oct 27, 1998

Defective sarcolemmal calcium pump in taurine deficient rats. FASEB Journal 3(4): A1060, 1989

Altered contraction-coupling in myocardium of hypertensive rats with transgenic renin overexpression. Circulation 92(8 SUPPL ): I239, 1995

Sarcolemmal sodium calcium exchange and calcium pump activities in cardiomyopathies due to intracellular calcium overload. Molecular & Cellular Biochemistry 82(1-2): 75-80, 1988

Effects of calcium antagonists on sodium calcium exchange and calcium pump activities of isolated cardiac sarcolemmal membrane. Journal of Molecular & Cellular Cardiology 19(SUPPL 1): S37, 1987

Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). Journal of Molecular and Cellular Cardiology 39(4): 647-656, 2005

SERCA2a-overexpression improves force-frequency and post-rest behaviour due to increased SR Ca-content in isolated myocardium of transgenic rats. European Heart Journal 21(Abstract Supplement): 530, August-September, 2000

The activity of the sarcolemmal Na pump determines the functional consequence of adenoviral Na/Ca exchanger overexpression. European Heart Journal 24(Abstract Supplement): 58, August-September, 2003

Sr calcium pump and sarcolemmal sodium calcium exchange in relaxation of cardiac muscle with and without ryanodine. Biophysical Journal 53(2 PART 2): 436A, 1988

Heart sarcolemmal sodium calcium exchange and calcium pump activities in chronic diabetes. Federation Proceedings 44(3): 830, 1985